Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2012

Feb 3, 2012

30071_dirs_2012-02-03_f4fb8aea-4e55-44cf-bf83-3b8b574f6b87.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2012-02-01

Reporting Person: Farrell Michael J. (President - Americas)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-02-01 ResMed Common Stock M 63 $15.52 Acquired 53399.665 Direct
2012-02-01 ResMed Common Stock S 63 $29.52 Disposed 53336.665 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-02-01 ResMed Common Stock Options $15.520 M 63 Disposed 2015-11-20 ResMed Common Stock (63) Direct

Footnotes

F1: Represents date options first became exercisable. Options vest 1/4 annually on the anniversary of the grant.